The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Unwin, Andrew John
    Director born in May 1964
    Individual (32 offsprings)
    Officer
    2022-01-31 ~ now
    OF - Director → CIF 0
    Mr Andrew John Unwin
    Born in May 1964
    Individual (32 offsprings)
    Person with significant control
    2022-01-31 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
parent relation
Company in focus

CONTRAST DIAGNOSTICS LTD

Standard Industrial Classification
86220 - Specialists Medical Practice Activities
Brief company account
Average Number of Employees
02023-04-01 ~ 2024-03-31
02022-01-31 ~ 2023-03-31
Property, Plant & Equipment
37,259 GBP2024-03-31
48,667 GBP2023-03-31
Fixed Assets - Investments
16,000 GBP2024-03-31
16,000 GBP2023-03-31
Fixed Assets
53,259 GBP2024-03-31
64,667 GBP2023-03-31
Debtors
8,551 GBP2024-03-31
1,005 GBP2023-03-31
Cash at bank and in hand
4,633 GBP2024-03-31
14,672 GBP2023-03-31
Current Assets
13,184 GBP2024-03-31
15,677 GBP2023-03-31
Creditors
Current
161,156 GBP2024-03-31
137,673 GBP2023-03-31
Net Current Assets/Liabilities
-147,972 GBP2024-03-31
-121,996 GBP2023-03-31
Total Assets Less Current Liabilities
-94,713 GBP2024-03-31
-57,329 GBP2023-03-31
Equity
Called up share capital
1,000 GBP2024-03-31
1,000 GBP2023-03-31
Retained earnings (accumulated losses)
-95,713 GBP2024-03-31
-58,329 GBP2023-03-31
Equity
-94,713 GBP2024-03-31
-57,329 GBP2023-03-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
55,062 GBP2023-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
17,803 GBP2024-03-31
6,395 GBP2023-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
11,408 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment
Plant and equipment
37,259 GBP2024-03-31
48,667 GBP2023-03-31
Investments in Group Undertakings
Cost valuation
16,000 GBP2023-03-31
Investments in Group Undertakings
16,000 GBP2024-03-31
16,000 GBP2023-03-31
Other Debtors
Amounts falling due within one year, Current
8,551 GBP2024-03-31
1,005 GBP2023-03-31
Trade Creditors/Trade Payables
Current
5,961 GBP2024-03-31
1,585 GBP2023-03-31
Other Creditors
Current
45,877 GBP2024-03-31
42,294 GBP2023-03-31

  • CONTRAST DIAGNOSTICS LTD
    Info
    Registered number 13883113
    88 East Stand Highbury Stadium Square, London, London N5 1FF
    Private Limited Company incorporated on 2022-01-31 (3 years 5 months). The company status is Active.
    The last date of confirmation statement was made at 2025-01-31
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.